Biggest News Aggregation in the World
📰 Nasdaq Bdtx News

Nasdaq Bdtx News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Nasdaq Bdtx. Real-time updates on events, politics, business and more.

Deerfield Management Company L.P. Series C Reduces Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)

Deerfield Management Company L.P. Series C lessened its stake in shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Free Report) by 48.3% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 930,447 shares of the company’s stock after selling 869,553 shares during […]
Deerfield Management Companylp Series Exchange Commission Jpmorgan Chase Co Bellevue Group Kennedy Capital Management Diamond Therapeutics Inc

Contrasting Black Diamond Therapeutics (NASDAQ:BDTX) & Beam Therapeutics (NASDAQ:BEAM)

Black Diamond Therapeutics (NASDAQ:BDTX – Get Free Report) and Beam Therapeutics (NASDAQ:BEAM – Get Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, risk and dividends. Insider & Institutional Ownership 80.6% of Beam […]
United States United Kingdom Pfizer Inc Therapeutics Inc Verve Therapeutics Inc Sana Biotechnology Inc

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Short Interest Up 12.8% in October

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Get Free Report) saw a significant increase in short interest in the month of October. As of October 31st, there was short interest totalling 3,350,000 shares, an increase of 12.8% from the October 15th total of 2,970,000 shares. Approximately 9.8% of the shares of the company are short sold. […]
Renaissance Technologies Capital Management Newtyn Management Diamond Therapeutics Inc Jump Financial Cubist Systematic Strategies

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Short Interest Up 24.3% in October

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Get Free Report) was the recipient of a significant increase in short interest in October. As of October 15th, there was short interest totalling 2,970,000 shares, an increase of 24.3% from the September 30th total of 2,390,000 shares. Approximately 8.7% of the shares of the company are short sold. […]
Piper Sandler Kennedy Capital Management Diamond Therapeutics Inc Diamond Therapeutics Company Profile Boothbay Fund Management Black Diamond Therapeutics

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Short Interest Up 24.6% in September

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Get Free Report) was the target of a large increase in short interest in September. As of September 15th, there was short interest totalling 1,420,000 shares, an increase of 24.6% from the August 31st total of 1,140,000 shares. Currently, 4.1% of the company’s stock are short sold. Based on […]
Black Diamond Ali Behbahani Stifel Nicolaus Piper Sandler Herbst Group Charles Schwab Investment Management Inc

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Short Interest Down 67.3% in July

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Get Free Report) saw a significant decline in short interest in the month of July. As of July 31st, there was short interest totalling 1,040,000 shares, a decline of 67.3% from the July 15th total of 3,180,000 shares. Based on an average trading volume of 4,090,000 shares, the days-to-cover […]
Black Diamond Davidm Epstein Stifel Nicolaus Piper Sandler Ali Behbahani Diamond Therapeutics Inc

Piper Sandler Initiates Coverage on Black Diamond Therapeutics (NASDAQ:BDTX)

Piper Sandler initiated coverage on shares of Black Diamond Therapeutics (NASDAQ:BDTX – Free Report) in a report released on Friday morning, Marketbeat Ratings reports. The firm issued an overweight rating and a $11.00 price objective on the stock. Other research analysts have also recently issued research reports about the stock. Wedbush upgraded shares of Black […]
Davidm Epstein Ali Behbahani Stifel Nicolaus Piper Sandler Marquette Asset Management Diamond Therapeutics Inc
Source: wkrb13.com

Black Diamond Therapeutics (NASDAQ:BDTX) Now Covered by Piper Sandler

Piper Sandler initiated coverage on shares of Black Diamond Therapeutics (NASDAQ:BDTX – Free Report) in a report published on Friday, MarketBeat.com reports. The firm issued an overweight rating and a $11.00 target price on the stock. Several other equities analysts also recently issued reports on BDTX. Stifel Nicolaus raised shares of Black Diamond Therapeutics from […]
Piper Sandler Stifel Nicolaus Ali Behbahani Healthcare Of Ontario Pension Plan Trust Fund Millennium Management Diamond Therapeutics Inc

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Major Shareholder Growth N. V. Biotech Buys 1,000,000 Shares

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Free Report) major shareholder Growth N. V. Biotech bought 1,000,000 shares of the business’s stock in a transaction that occurred on Friday, June 30th. The shares were bought at an average price of $5.00 per share, with a total value of $5,000,000.00. Following the completion of the purchase, the […]
Stifel Nicolaus Diamond Therapeutics Inc Securities Exchange Commission Cubist Systematic Strategies Diamond Therapeutics Company Profile Dimensional Fund Advisors

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science